Global Osteoporosis Market Analysed in New Market Report Now Available at MarketPublishers.com06 Sep 2011 • by Natalie Aster
LONDON – Total global osteoporosis market is forecast to achieve 16 billion by 2015. This boosting growth is first of all attributed to sustainable treatment options and strong pipeline products that are currently available on the market. The major driver of the market development today is the growth of osteoporosis cases among the female population.
The osteoporosis market is a principle source of market opportunities for both established and new marketers. The spread of information, increasing awareness and diagnosis and treatment advances all together are key incentives for new drugs development. Willing to maximize the revenues, pharma companies are seeking new ways of treatment and invest heavily in R&D.
New market research report “Global Osteoporosis Market & Drugs Analysis 2010 - 2015” worked out by Renub Research offers an in-depth coverage of the past, present and future landscape of the market. The report features latest available data including the following issues:
- global osteoporosis market during 2009 – 2015;
- four osteoporosis drug class market and market share data of 2006 trough 2014;
- top nine osteoporosis drug brands (Fosamax, Actonel, Reclast, Boniva, Evista, Forteo, Viviant/Conbriza, Miacalcin, Prolia), their sales and market share data up to 2015;
- six countries (USA, European Union, Japan, China, India, Korea) osteoporosis market share data starting with 2009 up to 2015;
- pipeline developmental agents (Odanacatib, Aprela) and future development;
- key companies (Eli Lilly, Roche, Amgen, Merck & Novartis) analysis including SWOT and revenue data.
Title: Global Osteoporosis Market & Drugs Analysis 2010 - 2015
Published: September, 2011
Price: US$ 950
1. EXECUTIVE SUMMARY
2. GLOBAL OSTEOPOROSIS MARKET
3. GLOBAL OSTEOPOROSIS MARKET SHARE (2007 – 2015)
3.1 By Drug Class - Osteoporosis Market Share & Forecast
3.2 By Drug Market Share - Osteoporosis Market Share & Forecast
3.3 By Country (USA, European Union, Japan, China, India, Korea) - Osteoporosis Drug Market Share & Forecast
4. BY COUNTRY – OSTEOPOROSIS MARKET & FORECAST (2008 – 2015)
4.1 United States Osteoporosis Market & Forecast
4.2 European Union Osteoporosis Market & Forecast
4.3 Japan Osteoporosis Market & Forecast
4.4 China Osteoporosis Market & Forecast
4.5 Korea Osteoporosis Market & Forecast
4.6 India Osteoporosis Market & Forecast
5. OSTEOPOROSIS DRUGS CLASSES MARKET & FORECAST (2004 – 2014)
5.1 Global Bisphosphonate Market & Forecast
5.2 Global Selective Estrogen Receptor Modulators (SERM) Market & Forecast
To order the report or ask for free sample pages, please contact email@example.com
The Market Publishers, Ltd.
Tel: +44 208 144 6009
Fax: +44 207 900 3970